Healthcare — FDA Launches Framework for Ultra-Rare Disease Therapies as Leadership Changes Rock CDC and Weight Loss Market Evolves

Healthcare · 2026-02-25

The healthcare industry is experiencing a fundamental shift toward personalized medicine and targeted therapeutics, marked by significant regulatory adaptation and market realignment. The FDA's new framework for ultra-rare disease therapies [PRIMARY SOURCE] represents a watershed moment in drug development, acknowledging the need for modified approval pathways when traditional clinical trials…